Trial intelligence / Profile preview

Phase 3 study of sufentanil in anesthesia/analgesia

2016-001603-23Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Oct 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of sufentanil in anesthesia and analgesia, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Oct 2016; status: completed.

02

Drugs

sufentanil
03

Conditions

anesthesia and analgesia

Beyond the preview

Go deeper on 2016-001603-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001603-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call